ℹ️
🇬🇧
Search
Search for people relevant for "Steven Pinker"
Steven Pinker
Person
Class
Person
Publication
Programmes
RNDr. Petr Pompach Ph.D.
Academic staff at Faculty of Science
1 class
56 publications
Class
class
Glycoconjugates and Imunochemistry
MC250P04N |
Faculty of Science
Publications
publication
The rapid detection of procalcitonin in septic serum using immunoaffinity MALDI chips
2023 |
Faculty of Science, Faculty of Medicine in Pilsen, Central Library of Charles University
publication
Cryo-EM structures of Trypanosoma brucei gambiense ISG65 with human complement C3 and C3b and their roles in alternative pathway restriction
2023 |
Faculty of Science, First Faculty of Medicine, Central Library of Charles University
publication
Insulin receptor Arg717 and IGF-1 receptor Arg704 play a key role in ligand binding and in receptor activation
2023 |
Faculty of Science, Central Library of Charles University
publication
Characterization of the interaction between the tumour suppressor p53 and heme and its role in the protein conformational dynamics studied by various spectroscopic techniques and hydrogen/deuterium exchange coupled with mass spectrometry
2023 |
Faculty of Science
publication
Preferred β-lactone synthesis can explain high rate of false-negative results in the detection of OXA-48-like carbapenemases
2022 |
Faculty of Medicine in Pilsen, Central Library of Charles University
publication
The impact of individual human cytochrome P450 enzymes on oxidative metabolism of anticancer drug lenvatinib
2022 |
Faculty of Science
publication
Fast Fluoroalkylation of Proteins Uncovers the Structure and Dynamics of Biological Macromolecules
2021 |
Faculty of Science, Central Library of Charles University
publication
Cytochrome P450 and flavin-containing monooxygenase enzymes are responsible for differential oxidation of the anti-thyroid-cancer drug vandetanib by human and rat hepatic microsomal systems
2020 |
Faculty of Science, Second Faculty of Medicine
publication
Identification of Enzymes Oxidizing the Tyrosine Kinase Inhibitor Cabozantinib: Cabozantinib Is Predominantly Oxidized by CYP3A4 and Its Oxidation Is Stimulated by cyt b(5) Activity
2020 |
Faculty of Science
publication
Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation
2019 |
Faculty of Science, Second Faculty of Medicine
Load more publications (46)
Loading network view...